LOVE, R. By the Metrics Surgical Oophorectomy Plus Tamoxifen is the First Adjuvant Treatment Option for Premenopausal Women with Hormone Receptor Positive Breast Cancer. Archives of Breast Cancer, [S. l.], p. 8–13, 2021. DOI: 10.32768/abc.2021818-13. Disponível em: https://archbreastcancer.com/index.php/abc/article/view/337. Acesso em: 22 dec. 2024.